Precision Biosciences DTIL
NASDAQ DTIL
$6.76 +0.05 (+0.75%)
As of: Oct 22, 2026 · 2:38 PM EDT

Precision Biosciences (DTIL) Share-based Compensation (IS) (2025 - 2026)

Updated

Precision Biosciences (DTIL) recorded Share-based Compensation (IS) of $1.84 million in fiscal Q2 2026 (quarter ended Jun 30, 2026), down 37.2% from $2.94 million a year earlier.

Analysis

Precision Biosciences (DTIL) Share-based Compensation (IS) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn -
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn -
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn -
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn -
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn -
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn -
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn -
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn -
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn -
10 Precision Biosciences 174.79 Mn -174.40 Mn - 1.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.84 Mn
Jun 30, 2025 2.94 Mn
API Access

Precision Biosciences Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DTIL&period=max&api_key=YOUR_API_KEY